GARVAN INSTITUTE OF MEDICAL RESEARCH;PETER MACCALLUM CANCER INSTITUTE
发明人:
Alex SWARBRICK,Iva NIKOLIC,Kaylene SIMPSON
申请号：
US16307374
公开号：
US20190300882A1
申请日:
2017.06.07
申请国别(地区):
US
年份:
2019
代理人:
摘要：
This disclosure relates to RNA interference (RNAi) reagents for treatment of neuroblastoma, compositions comprising same, and use thereof to treat individuals suffering from neuroblastoma as a monotherapy or in combination with a chemotherapeutic agent. In particular, the present disclosure relates to microRNAs (miRNAs) which affect viability of neuroblastoma cells.
